Abstract
Purpose of Review
This review provides a recent update of behavioral research pertinent to young children with T1D and addresses current priorities and future directions.
Recent Findings
Rates of type 1 diabetes (T1D) in young children (ages 1–7) are continuing to rise. Since 2014, changes to diabetes care and management have impacted young children and reinforced the need for increased attention and interventions to support diabetes management, especially in caregivers who are primarily responsible for their young child’s diabetes management.
Summary
T1D is associated with unique physiologic challenges in young children, with constant management demands elevating parental diabetes-related stress and fear of hypoglycemia. Diabetes technology use has significantly increased in young children, contributing to improvements in glycemic levels and parent and child psychosocial functioning. Yet despite the positive outcomes demonstrated in select clinical behavioral interventions, research with this young child age group remains limited in scope and quantity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Rates of type 1 diabetes (T1D) are continuing to rise, and 18% of new diagnoses occur in children ages 9 and younger [1]. In 2014, Current Diabetes Reports published a review of diabetes management in young children with T1D, highlighting challenges of T1D management, current research within this population, and opportunities for future research and clinical care [2]. Since 2014, numerous changes in the clinical diabetes landscape have impacted young children. Research has reinforced the importance of maintaining glucose levels in a tight target range for youth with T1D of all ages [3]. Current glycemic goals recognized by the American Diabetes Association (ADA) and the International Society of Pediatric and Adolescent Diabetes (ISPAD) recommend that young children maintain an A1c level < 7.0% when possible and without risk of severe hypoglycemia [3, 4]. Further, young children with T1D are the fastest adopters of diabetes technologies, including insulin pumps and continuous glucose monitors (CGMs) [5, 6], with significant implications for both glycemic indicators and parent and child psychosocial functioning. However, recent data from the T1D Exchange found a mean A1c of 8.2% in children less than 6 years of age [5], suggesting this age group would benefit from increased attention and interventions to support diabetes management.
Many challenges to diabetes management in young children identified in the 2014 article still remain [2]. Parents continue to take primary responsibility for diabetes management in young children. Diabetes management is complicated by normative development in toddlers and preschoolers, including rapid physical and neurological development, difficulty verbalizing thoughts and feelings, frequent and unpredictable physical activity, picky eating, and behavioral challenges and fears [2]. Additionally, many clinical T1D management programs do not offer tailored patient education specifically designed to meet the needs of young children. Given these unique management and developmental considerations, parents of young children have been increasingly targeted for behavioral interventions. In the USA, some of these newer intervention trials were funded in response to a 2013 Request for Applications by the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) calling for interventions to improve diabetes management in families with young children with T1D [7]. The goal of this article is to review new research with young children with T1D (typically ages 1–7) that has been published since 2014, with an emphasis on technology use and behavioral interventions.
Parental Initial Adjustment
Following their young child’s T1D diagnosis, parents typically oversee all aspects of their young child’s comprehensive T1D regimen [8]. Given this immense responsibility, parents may experience diabetes-related distress, a negative emotional response to the burdens of managing their young child’s diabetes regimen, during the initial months following their child’s diagnosis and beyond [9]. Qualitative research suggests that many parents report difficulty returning to normalcy after diagnosis due to feeling “on guard all of the time” and hesitancy to trust other caregivers to manage their young child’s diabetes regimen [10]. Mothers often report higher distress soon after their child’s T1D diagnosis compared to fathers [11]. Social support during the initial diagnosis period may be protective for parents and associated with decreased stress. Specifically, our recent research found that more family support predicted less stress in mothers, and more partner support predicted less stress in fathers [12].
Physiologic Challenges
Early-onset T1D places young children at an increased risk for neurocognitive impacts. Using both comprehensive neurocognitive testing and high-resolution structural magnetic resonance imaging (MRI), Mauras and colleagues found that young children with T1D did not differ from their counterparts without T1D in assessments of cognition and executive functioning, but children with T1D had observed differences in brain matter growth [13]. Slower brain development was associated with higher cumulative hyperglycemia and glucose variability among young children with T1D [13]. Another study observed similar structural findings, yet also found subtle cognitive differences in children with T1D compared to children without T1D, including in participants who had been recently diagnosed with T1D (T1D duration in study ranged from 0.1 to 7.9 years). This study also found a trending association among DKA and severe hypoglycemia history and IQ scores. This research suggests that glycemic indicators may have detrimental impacts on the developing brain [14]. In a longitudinal study, Kirchhoff and colleagues observed differences in cognitive function between youth with T1D and their similarly aged relatives without diabetes, with the decreased cognitive function being associated with both increased hyperglycemia and earlier age of onset of T1D, which can cause challenges to the developmental trajectory of cognitive processes [15, 16].
Young children are at increased risk for diabetic ketoacidosis (DKA) at T1D onset [17, 18]. DKA at diagnosis of T1D has been associated with higher A1c levels over time and a negative impact on cognitive functioning [19, 20]. Aye and colleagues found that DKA at diagnosis in young children was associated with lower cognitive scores as assessed by IQ tests, the Detectability and Commission subtests of the Conners’ Continuous Performance Test II, and the Dot Locations subtest of the Children’s Memory Scale (Mtime since diagnosis = 2.8 years) [20]. Development of or improvements to public health educational programs focused on helping families and primary care physicians detect early signs of T1D and DKA may be beneficial to reduce the negative impact on young children’s cognitive development [21].
Given developmental expectations for young children, including limited language abilities and unpredictable eating and activity patterns, there are often more concerns for hypoglycemia than in older children with T1D [22]. Further, young children often take smaller, more precise doses of insulin and have higher sensitivity to insulin than older youth [2]. Recent research has found that parents may intentionally maintain their young children’s blood glucose at higher levels to avoid low blood glucose levels and the adverse effects of hypoglycemia [22, 23]. Parental fear of hypoglycemia may interfere with achievement of updated glycemic targets that recommend tighter glycemic ranges [24], which is problematic given the aforementioned research linking chronic hyperglycemia with negative cognitive impacts. As noted earlier, since the publication of the 2014 review, the recommended target A1c for young children (children ≤ 6) changed from < 8.5 to < 7%, which reflects the current goal for all individuals with T1D regardless of age. The A1c goal was changed with the aim of avoiding long-term vascular complications, hyperglycemia, and hypoglycemia to ensure children have the highest chance of a healthy life with minimal diabetes-related complications, especially looking toward adulthood. While this more conservative A1c goal may be more difficult for families to reach, the International Society of Pediatric and Adolescent Diabetes note the lowered target is intended as an aspirational goal, as people who with a lower target goal range for glycemic levels tend to have lower A1c levels [3, 25, 26].
Nutrition
Dietary quality and parent management of mealtime behaviors are important aspects of diabetes management in young children [27]. Research has found that while parents of young children generally know what healthy eating entails, they do not always follow healthy eating patterns because of barriers to feeding and dietary intake [28]. Our nutrition research evaluating breakfast dietary quality in a sample of young children with T1D found that less than half met dietary recommendations for protein and fat (46% each), and even fewer met dietary recommendations for carbohydrates (23%) [29]. Parent-identified challenges to feeding their child with T1D a healthy diet may include (1) cost and availability of healthy foods, (2) picky eating tendencies in young children, (3) desire to maintain same food options as siblings and peers, and (4) difficulties getting younger children to try new foods. It is not surprising that behavior at mealtimes can be stressful for parents. Younger child age has been associated with more frequent mealtime behavior problems, which are associated with elevated glycemic levels in young children with T1D [30]. Parents also report experiencing worry about administering insulin before meals as appetites vary, particularly in this young child age group [28].
In recent years, research has identified beneficial techniques used around mealtimes to maintain in-range glycemic levels. Seckold and colleagues found that glycemic targets were more likely to be met when children were given insulin before meals and followed a consistent eating schedule for meals, rather than grazing throughout the day [31]. Implementing effective approaches such as providing support to parents of young children with problematic eating behaviors via trained counselors or parent coaches [32••], focusing on the nutritional make up of children’s meals [33], and maintaining routines around meal times [31] also may help improve glycemic levels in young children.
Physical Activity
Ensuring physical activity is performed in a safe, and healthy manner is an additional challenge of T1D management in young children, as parents may be fearful of hypoglycemia brought on by physical activity [34]. While minimal research on physical activity has been conducted with young children, physical activity is beneficial in maintaining healthy weight and glycemic levels in older children and adolescents with T1D [35]. National guidelines by the Physical Activity Guidelines Advisory Committee recommend that most young children engage in 3 hours of light, moderate, and/or vigorous activity per day, and ISPAD recommends children with T1D complete the same amount of exercise as children in the general population [35, 36]. Yet, Tully and colleagues (2018) examined physical activity in a small sample of young children ages 3–7 with T1D and found that the sample spent most of their day in sedentary behavior and were less active than published samples of young children without T1D [34].
Psychosocial Functioning
T1D management in young children is often described as all-encompassing and unrelenting, and parents of children with T1D endorse significant burdens associated with T1D management [37]. Harrington and colleagues analyzed survey data from 597 young children <7 years of age with T1D, finding that the following burdens were endorsed by over half of all parents: (1) worry about low blood sugar, (2) worry about future complications, (3) feeling upset when diabetes management is “off track,” and (4) negative impact on sleep quantity and quality [38]. These burdens can have a negative impact both on family functioning (e.g., family well-being, family conflict) and on individual parental psychosocial functioning (e.g., mood, stress, quality of life).
Studies suggest that parental adjustment is associated with young children’s T1D outcomes and quality of life [39]. In one study, higher levels of parenting stress contributed to lower diabetes-related quality of life in both parents and children [40]. Our research demonstrated that key child protective factors (e.g., initiative, self-control, and attachment) were associated with more optimal parental functioning (e.g., lower depression and stress symptoms) and higher child quality of life [41]. Additionally, Jaser and colleagues found that sleep quality in young children with T1D is associated with parental sleep and well-being [42]. Thus, parental psychosocial functioning appears to be a key factor in the well-being of young children with T1D.
Due in part to developmental limitations for child self-report in young children, research to date has mainly relied on parental report of child psychosocial functioning, with fewer investigations exploring adjustment or quality of life of young children themselves. In one study, parents rated young children with T1D as having lower health-related quality of life compared to a comparison group of children without T1D [43]. Yet, in other studies, parent ratings provided evidence of diabetes-related resilience by demonstrating no difference in health-related quality of life or functioning between young children with or without T1D [44]. Developmentally tailored measures to assess parent and child functioning in this unique population of young children are needed, and some new measures have emerged in recent years. For example, Enlow and colleagues developed and validated the Parent-Preschoolers Diabetes Adjustment Scale to evaluate caregiver adjustment to the challenges and demands of parenting a young child with T1D [45].
Parental Coping and Resilience
While overseeing their child’s T1D management is a complex and intensive task for parents, many parents display resilience. Pierce and colleagues found that most parents of young children with T1D engaged in positive coping strategies [39], including defining a “new normal” for their family, engaging in creative problem-solving, and benefit finding (positive perceptions in the face of adversity). Expanding on the advantage of benefit finding in their later work, this group also found that benefit finding was correlated with higher parental diabetes self-efficacy [46]. Parental diabetes self-efficacy, defined as parents’ perceived ability to oversee diabetes care tasks, is an important component of managing diabetes for a young child [47]. In our unpublished data from a stepped care behavioral intervention [48], we found that parental diabetes self-efficacy improves over the first year and a half after diagnosis, and long-term parental diabetes self-efficacy was predicted by parental psychosocial functioning at diagnosis [49]. However, there is limited research examining interventions to promote parental diabetes self-efficacy and further investigation is warranted.
Other Caregivers
Responsibilities for managing a young child’s diabetes are often shared with other caregivers—such as teachers, day care providers, and nurses—corroborating the idea that T1D management in young children is a team effort [50–52]. In a recent study of kindergarten teachers, most rated their T1D knowledge and ability to assist with diabetes tasks as fair, and many identified opportunities for improved institutional support and communication with parents and health care providers [50]. Similarly, pre-kindergarten and kindergarten school nurses reported confidence in their ability to care for children with T1D [52]. Daycare poses additional considerations for parents. In fact, some parents reported that daycare utilization was significantly impacted by diabetes-related financial stress and need for flexibility related to managing their child’s diabetes [53]. Further, parents of children with more diabetes-related complications (diabetes-related unconsciousness or seizures) and higher fear of hypoglycemia expressed increased concerns for their child’s functioning in daycare or school [51]. For some families, recent advances in diabetes technologies have increased ease of sharing diabetes responsibilities with other caregivers, but not all young children have the same opportunities for access and use. Halipchuk and Sawatsky call for increased use of flexible insulin regimens in toddlers, such as basal-bolus regimens or insulin pumps, to help facilitate insulin administration in daycares and schools [54].
Technology
Diabetes technologies, such as insulin pumps and CGMs, are evolving tools for diabetes management, and use of these technologies in young children has significantly increased in recent years [55]. Recent data from the T1D Exchange indicate that CGM use in children less than 6 years old has increased over 40% from 2011 to 2016 [56] and insulin pump use nearly doubled, with the highest rates of use in the youngest patients [43, 57]. Hybrid closed loop systems, which automatically adjust insulin delivery according to glucose levels aside from mealtime boluses, are relatively novel in young children, with a recent trial indicating that they are feasible and safe to use [58]. Household sociodemographic factors have significant impacts on access and consistent use of diabetes devices [59]. Families with private insurance are more likely to use a CGMs, and young children with a longer T1D duration, an annual household income of > $75,000, a parent with college education, and using a CGM are more likely to use a pump [60, 61]. Further, these technology advances have exacerbated racial disparities in diabetes treatment, with non-Hispanic White children being more likely to be prescribed and use insulin pumps and CGMs than non-Hispanic Black and Hispanic children [62].
Research has demonstrated that diabetes technologies improve glycemic levels and may reduce the burden of diabetes management in young children and their parents [63, 64]. Several studies have shown that children using a CGM have fewer sleep disturbances [65, 66••, 67]. Further, Burckhardt and colleagues found that CGM use may provide a greater sense of freedom for children and their parents (e.g., being able to spend time away from home) and improve communication between parents and other caregivers (e.g., teachers) [68]. Similarly, parents of young children using hybrid closed loop systems reported spending less time performing diabetes activities, resulting in feeling reassured and perceived improvements in their child’s quality of life [66••].
While there is increased use and identified benefits of CGMs and pumps, challenges still arise for young children and their parents. Children have reported that CGMs and pumps were painful to insert and wear, specifically reporting skin adhesive difficulties and extra discomfort when wearing both devices [60, 65]. Other burdens reported by parents include incomplete glycemic data due to connectivity issues [65, 66••], financial barriers to ongoing use (e.g., insurance stopped covering, too expensive) [60], and battery performance [66••].
There are mixed findings regarding the impact of technology on parents’ sleep and regarding parents’ impressions of glucose data interpretation and device alarms. Our work found greater parent sleep disturbances related to CGM use due to nighttime blood glucose monitoring [67], while Burkhardt and colleagues found that parents reported improved sleep quality after initiating CGM in their young children [68]. Similarly, with CGMs offering continuous and extensive blood glucose data, some parents have found this information overwhelming and difficult to interpret, while others have found being able to visualize their child’s blood glucose levels, trends, and patterns relieving [65, 68]. Moreover, Musolino and colleagues found that alarms from diabetes technologies related to glucose excursions were either perceived by parents as intrusive (i.e., causing anxiety), or reassuring (i.e., creating peace of mind) [66••]. It is important to note that evolving capabilities of diabetes technology influence parental experiences. Similarly, many studies report on older versions of technologies, which may account for some of the inconsistencies seen in the literature (e.g., CGM systems that required calibration with blood glucose values obtained via glucometer or were less reliable). It is essential that future work evaluating diabetes technologies include assessments of child and parent experience to fully capture the benefits and challenges of using these devices.
Interventions
A number of clinical behavioral interventions for young children with T1D are new or in progress, with results forthcoming. With the Request for Applications by the National Institutes of Health (NIH) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), promising studies are emerging, but they need to be replicated [7]. The majority of interventions have targeted caregivers of young children with T1D (see Table 1 for an overview of representative interventions). Existing interventions for parents of young children target skills for reducing hypoglycemia distress [69••], healthy eating and physical activity promotion [34], managing diabetes challenges [70], and optimizing CGM use [71••]. Through these interventions, several benefits for parents have been achieved including reduced hypoglycemia fear [69••], decreased stress [69••, 70] and diabetes burden [71••], and improved social support [72], quality of life [70, 72], and well-being [71••]. Young children also benefited from these interventions as evidenced by improvements in glycemic levels [32••, 34, 70]. Our work evaluating a stepped-care behavioral intervention aimed to support parents’ psychosocial functioning found that parent coaching is feasible and improves parents’ mood over the first year after a child’s diagnosis. Additionally, interventions for other caregivers may also be warranted yet remain understudied. For example, one study utilized a video training program to improve primary school teachers’ confidence in administering glucagon and found significant improvements in confidence and knowledge [73••]. There are also ongoing and unpublished interventions aimed at improving both parent and young child outcomes, including a positive parenting program [74], educational videos [75], and a web-based coping resource [76]. Additionally, Berget and colleagues are utilizing a sequential multiple assignment randomization trial (SMART) design to increase family adherence to CGM use and improve the quality of life of parents with young children with T1D [77].
Current Issues
Recently, studies have described the experience of managing diabetes in children during the COVID-19 pandemic [78,79,80]. Our team followed a cohort of parents of children (n = 100) who were diagnosed with T1D at a young age (1–6 years, pre-pandemic) who had completed a behavioral trial more than 6 months prior (enrolled between 2015–2019), and obtained data for 2 additional follow-up times points during the pandemic (Summer 2020, Winter 2021 [81]). During Summer, 2020, parents of children with T1D (M age = 6.74 years) who reported experiencing more pandemic-related life disruptions during the initial months of the pandemic also reported more negative diabetes-specific experiences as well as COVID-19-specific distress. Further, parents of young children with T1D who had higher social support pre-pandemic reported fewer depressive symptoms during Summer, 2020 [81].
Similar to other ongoing behavioral interventions [82], research focused on young children and T1D has adapted over the last few years to accommodate reliance on telehealth diabetes visits [83]. The necessity for remote delivery of interventions across this time period may prove advantageous for the future of intervention delivery, maximizing family convenience and reducing barriers that are commonly reported regarding participation in research [84, 85]. It is also possible that remote enrollment and intervention delivery may translate to increased diversity among future research samples.
Conclusions and Future Directions
Although ADA and ISPAD no longer include less conservative glycemic targets for young children as they did prior to 2015 [86, 87], there has been an increased recognition of the unique factors faced by children diagnosed with T1D at a young age, as well as the impact on their family members. As such, the research focused on young children with T1D has continued to grow over the last decade, and we expect further expansion of investigations targeting this young child age group to come. Behavioral interventions that show promise for both child and parent psychosocial functioning, as well as child glycemic outcomes, have been largely elusive to date. However, we remain optimistic that the behavioral strategies and related positive outcomes demonstrated thus far (i.e., improvements in parent distress, hypoglycemia fear, child well-being, and glycemic outcomes [34, 69••, 70, 71••]) could be incorporated into routine clinical care. Additionally, increasing social support appears to be a key mechanism to promote parent and child psychosocial functioning. Future research should include evaluation of these interventions into the clinical or real-world setting with representative samples of youth and parents reflecting diverse racial, ethnic, and socioeconomic groups, which will ultimately improve the well-being of young children with T1D and their family members.
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Lawrence JM, Divers J, Isom S, Saydah S, Imperatore G, Pihoker C, Marcovina SM, Mayer-Davis EJ, Hamman RF, Dolan L, Dabelea D, Pettitt DJ, Liese AD. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001–2017. JAMA. 2021;326(8):717–27. https://doi.org/10.1001/jama.2021.11165.
Streisand R, Monaghan M. Young children with type 1 diabetes: challenges, research, and future directions. Curr Diab Rep. 2014;14(9):520. https://doi.org/10.1007/s11892-014-0520-2.
American Diabetes Association. 13 children and adolescents: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S180–99. https://doi.org/10.2337/dc21-S013.
DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391(10138):2449–62. https://doi.org/10.1016/s0140-6736(18)31320-5.
Foster N, Beck R, Miller K, Clements M, Rickels M, DiMeglio L, Maahs D, Tamborlane W, Bergenstal R, Smith E, Olson B, Garg S, for the T1D Exchange Clinic Network. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol Ther. 2019;21(2):66–72. https://doi.org/10.1089/dia.2018.0384.
Miller VA, Xiao R, Slick N, Feudtner C, Willi SM. Youth involvement in the decision to start CGM predicts subsequent CGM use. Diabetes Care. 2020;43(10):2355–61. https://doi.org/10.2337/dc20-0348.
Improving diabetes management in young children with type 1 diabetes (DP3). 2013. https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-022.html. Accessed 12 Dec 2021
Commissariat PV, Harrington KR, Whitehouse AL, Miller KM, Hilliard ME, Van Name M, DeSalvo DJ, Tamborlane WV, Anderson BJ, DiMeglio LA, Laffel LM. “I’m essentially his pancreas”: parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes. Pediatr Diabetes. 2020;21(2):377–83. https://doi.org/10.1111/pedi.12956.
Noser AE, Dai H, Marker AM, Raymond JK, Majidi S, Clements MA, Stanek KR, Patton SR. Parental depression and diabetes-specific distress after the onset of type 1 diabetes in children. Health Psychol. 2019;38(2):103–12. https://doi.org/10.1037/hea0000699.
Iversen AS, Graue M, Haugstvedt A, Raheim M. Being mothers and fathers of a child with type 1 diabetes aged 1 to 7 years: a phenomenological study of parents’ experiences. Int J Qual Stud Health Well-being. 2018;13(1):1487758. https://doi.org/10.1080/17482631.2018.1487758.
Nieuwesteeg A, Hartman E, Emons W, van Bakel H, Aanstoot HJ, van Mil E, Pouwer F. Paediatric parenting stress in fathers and mothers of young children with type 1 diabetes: a longitudinal study. Diabet Med. 2017;34(6):821–7. https://doi.org/10.1111/dme.13300.
Wang CH, Tully C, Monaghan M, Hilliard ME, Streisand R. Source-specific social support and psychosocial stress among mothers and fathers during initial diagnosis of type 1 diabetes in young children. Fam Syst Health. 2021;39(2):358–62. https://doi.org/10.1037/fsh0000610.
Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, Hershey T, Cato A, Cheng P, Kollman C, Beck RW, Ruedy K, Aye T, Fox L, Arbelaez AM, Wilson D, Tansey M, Tamborlane W, Peng D, Marzelli M, Winer KK, Reiss AL. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015;64(5):1770–9. https://doi.org/10.2337/db14-1445.
Cato MA, Mauras N, Mazaika P, Kollman C, Cheng P, Aye T, Ambrosino J, Beck RW, Ruedy KJ, Reiss AL, Tansey M, White NH, Hershey T. Longitudinal evaluation of cognitive functioning in young children with type 1 diabetes over 18 months. J Int Neurospychol Soc. 2016;22(3):293–302. https://doi.org/10.1017/s1355617715001289.
Kirchhoff BA, Jundt DK, Doty T, Hershey T. A longitudinal investigation of cognitive function in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2017;18(6):443–9. https://doi.org/10.1111/pedi.12414.
Hosseini SM, Mazaika P, Mauras N, Buckingham B, Weinzimer SA, Tsalikian E, White NH, Reiss AL. Altered integration of structural covariance networks in young children with type 1 diabetes. Hum Brain Mapp. 2016;37(11):4034–46. https://doi.org/10.1002/hbm.23293.
Praveen PA, Hockett CW, Ong TC, Amutha A, Isom SP, Jensen ET, Mohan V, Dabelea DA, D’Agostino RB Jr, Hamman RF, Mayer-Davis EJ, Lawrence JM, Dolan LM, Kahn MG, Madhu SV, Tandon N. Diabetic ketoacidosis at diagnosis among youth with type 1 and type 2 diabetes: results from SEARCH (United States) and YDR (India) registries. Pediatr Diabetes. 2021;22(1):40–6. https://doi.org/10.1111/pedi.12979.
Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S, Imperatore G, D’Agostino RB Jr, Mayer-Davis EJ, Pihoker C. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45. https://doi.org/10.1542/peds.2013-2795.
Duca LM, Reboussin BA, Pihoker C, Imperatore G, Saydah S, Mayer-Davis E, Rewers A, Dabelea D. Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study. Pediatr Diabetes. 2019;20(2):172–9. https://doi.org/10.1111/pedi.12809.
Aye T, Mazaika PK, Mauras N, Marzelli MJ, Shen H, Hershey T, Cato A, Weinzimer SA, White NH, Tsalikian E, Jo B, Reiss AL, Diabetes Research in Children Network Study Group. Impact of early diabetic ketoacidosis on the developing brain. Diabetes Care. 2019;42(3):443–9. https://doi.org/10.2337/dc18-1405.
Iovane B, Cangelosi AM, Bonaccini I, Di Mauro D, Scarabello C, Panigari A, Tiri A, Mastrorilli C, Fainardi V, Dodi I, Vanelli M. Diabetic ketoacidosis at the onset of type diabetes in young children is it time to launch a tailored campaign for DKA prevention in children <5 years? Acta Biomed. 2018;89(1):67–71. https://doi.org/10.23750/abm.v89i1.6936.
Tansey M, Beck R, Ruedy K, Tamborlane W, Cheng P, Kollman C, Fox L, Weinzimer S, Mauras N, White NH, Tsalikian E, Diabetes research in children network. Persistently high glucose levels in young children with type 1 diabetes. Pediatr Diabetes. 2016;17(2):93–100. https://doi.org/10.1111/pedi.12248.
Van Name MA, Hilliard ME, Boyle CT, Miller KM, DeSalvo DJ, Anderson BJ, Laffel LM, Woerner SE, DiMeglio LA, Tamborlane WV. Nighttime is the worst time: parental fear of hypoglycemia in young children with type 1 diabetes. Pediatr diabetes. 2018;19(1):114–20. https://doi.org/10.1111/pedi.12525.
Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl 20):180–92. https://doi.org/10.1111/pedi.12174.
Chiang JL, Kirkman MS, Laffel LMB, Peters AL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–54. https://doi.org/10.2337/dc14-1140.
DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):105–14. https://doi.org/10.1111/pedi.12737.
Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl 1):S61-78. https://doi.org/10.2337/dc08-s061.
Patton SR, Clements MA, George K, Goggin K. “I don’t want them to feel different”: a mixed methods study of parents’ beliefs and dietary management strategies for their young children with type 1 diabetes mellitus. J Acad Nutr Diet. 2016;116(2):272–82. https://doi.org/10.1016/j.jand.2015.06.377.
Mackey ER, Rose M, Tully C, Monaghan M, Hamburger S, Herrera N, Streisand R. The current state of parent feeding behavior, child eating behavior, and nutrition intake in young children with type 1 diabetes. Pediatr Diabetes. 2020;21(5):841–5. https://doi.org/10.1111/pedi.12997.
Monaghan M, Herbert L, Wang J, Holmes C, Cogen F, Streisand R. Mealtime behavior and diabetes-specific parent functioning in young children with type 1 diabetes. Health Psychol. 2015;34(8):794–801. https://doi.org/10.1037/hea0000204.
Seckold R, Howley P, King B, Bell K, Smith A, Smart C. Dietary intake and eating patterns of young children with type 1 diabetes achieving glycemic targets. BMJ Open Diabetes Res Care. 2019;7(1):e000663. https://doi.org/10.1136/bmjdrc-2019-000663.
•• Mackey ER, Tully C, Rose M, Hamburger S, Wang J, Herrera N, Cogen F, Henderson C, Monaghan M, Hornack S, Streisand R. Promoting glycemic control in young children with type 1 diabetes: results from a pilot intervention for parents. Fam Syst Health. (in press). A healthy eating and physical activity behavioral intervention demonstrated high acceptability and an increased number of young children with T1D within target glycemic range.
Monzon AD, Smith LB, Powers SW, Dolan LM, Patton SR. The association between glycemic variability and macronutrients in young children with t1d. J Pediatr Psychol. 2020;45(7):749–58. https://doi.org/10.1093/jpepsy/jsaa046.
Tully CB, Toaff M, Herbert L, DiPietro L, Henderson C, Cogen F, Streisand R. Acceptability and feasibility of examining physical activity in young children with type 1 diabetes. J Pediatric Health Care. 2018;32(3):231–5. https://doi.org/10.1016/j.pedhc.2017.10.004.
Adolfsson P, Riddell MC, Taplin CE, Davis EA, Fournier PA, Annan F, Scaramuzza AE, Hasnani D, Hofer SE. ISPAD clinical practice consensus guidelines 2018: exercise in children and adolescents with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):205–26. https://doi.org/10.1111/pedi.12755.
2018 Physical Activity Guidelines Advisory Committee. Part F. Chapter 7. Youth. In: 2018 Physical Activity Guidelines Advisory Committee Scientific Report to the Secretary of Health and Human Services. 2018. https://health.gov/sites/default/files/2019-09/13_F-7_Youth.pdf. Accessed 10 Nov 2021.
Kimbell B, Lawton J, Boughton C, Hovorka R, Rankin D. Parents’ experiences of caring for a young child with type 1 diabetes: a systematic review and synthesis of qualitative evidence. BMC Pediatr. 2021;21(1):160. https://doi.org/10.1186/s12887-021-02569-4.
Harrington KR, Boyle CT, Miller KM, Hilliard ME, Anderson BJ, Van Name M, Di Meglio LA, Laffel LM, T1D Exchange Clinic Network. Management and Family Burdens Endorsed by Parents of Youth <7 Years Old With Type 1 Diabetes. J Diabetes Sci Technol. 2017;11(5):980–7.
Pierce JS, Kozikowski C, Lee JM, Wysocki T. Type 1 diabetes in very young children: a model of parent and child influences on management and outcomes. Pediatr Diabetes. 2017;18(1):17–25. https://doi.org/10.1111/pedi.12351.
Nieuwesteeg AM, Hartman EE, Aanstoot HJ, van Bakel HJ, Emons WH, van Mil E, Pouwer F. The relationship between parenting stress and parent-child interaction with health outcomes in the youngest patients with type 1 diabetes (0–7 years). Eur J Pediatr. 2016;175(3):329–38. https://doi.org/10.1007/s00431-015-2631-4.
Monaghan M, Clary L, Stern A, Hilliard ME, Streisand R. Protective factors in young children with type 1 diabetes. J Pediatr Psychol. 2015;40(9):878–87. https://doi.org/10.1093/jpepsy/jsv041.
Jaser SS, Foster NC, Nelson BA, Kittelsrud JM, DiMeglio LA, Quinn M, Willi SM, Simmons JH, Network TDEC. Sleep in children with type 1 diabetes and their parents in the T1D Exchange. Sleep Med. 2017;39:108–15. https://doi.org/10.1016/j.sleep.2017.07.005.
Sundberg F, Nåtman J, Franzen S, Åkesson K, Särnblad S. A decade of improved glycemic control in young children with type 1 diabetes: a population-based cohort study. Pediatr Diabetes. 2021;22(5):742–8. https://doi.org/10.1111/pedi.13211.
Lukács A, Bettina Zagraj V, Bartkóné Kovács A, Soós A, Török A, Barkai L. Health-related quality of life of preschool-aged children with type 1 diabetes in the context of family and maternal functioning. J Child Health Care. 2021;2021:1367493521995320. https://doi.org/10.1177/1367493521995320.
Enlow PT, Wasserman R, Aroian K, Lee J, Wysocki T, Pierce J. Development and validation of the parent-preschoolers diabetes adjustment scale (PP-DAS). J Pediatr Psychol. 2020;45(2):170–80. https://doi.org/10.1093/jpepsy/jsz093.
Pierce JS, Wasserman R, Enlow P, Aroian K, Lee J, Wysocki T. Benefit finding among parents of young children with type 1 diabetes. Pediatr Diabetes. 2019;20(5):652–60. https://doi.org/10.1111/pedi.12860.
Streisand R, Mackey E, Elliot B, Mednick L, Slaughter I, Turek J, Austin A. Parental anxiety and depression associated with caring for a child newly diagnosed with type 1 diabetes: opportunities for education and counseling. Patient Educ Couns. 2008;73(2):333–8 https://doi.org/S0738-3991(08)00324-8 [pii].
Hilliard M, Tully C, Monaghan M, Wang J, Streisand R. Design and development of a stepped-care behavioral intervention to support parents of young children newly diagnosed with type 1 diabetes. Contemp Clin Trials. 2017;62:1–10. https://doi.org/10.1016/j.cct.2017.08.009.
Moore H, Inverso H, Rooney K, Tully C, Monaghan M, Hilliard ME, Streisand R, Wang, CH. Elevated depressive symptoms, stress, and parent diabetes self-efficacy among parents of young children newly diagnosed with type 1 diabetes. International Society for Pediatric and Adolescent Diabetes 47th Annual Conference. Virtual, 2021.
Gutzweiler RF, Neese M, In-Albon T. Teachers’ perspectives on children with type 1 diabetes in German kindergartens and schools. Diabetes Spectr. 2020;33(2):201–9. https://doi.org/10.2337/ds19-0054.
Herbert LJ, Clary L, Owen V, Monaghan M, Alvarez V, Streisand R. Relations among school/daycare functioning, fear of hypoglycaemia and quality of life in parents of young children with type 1 diabetes. J Clin Nurs. 2015;24(9–10):1199–209. https://doi.org/10.1111/jocn.12658.
Williams LF, Russ M, Perdue BJ. Exploration of school nurses’ perception of self-efficacy in providing care and education to children with type 1 diabetes mellitus. J Natl Black Nurses Assoc. 2019;30(2):34–7. https://doi.org/10.1080/02739615.2015.1124776.
Herbert LJ, Wall K, Monaghan M, Streisand R. Parent employment and school/daycare decisions among parents of young children with type 1 diabetes. Child Health Care. 2017;46(2):170–80. https://doi.org/10.1080/02739615.2015.1124776.
Halipchuk J, Sawatsky L. Toddlers with type 1 diabetes in daycare: issues with administering insulin lessen options. Can J Diabetes. 2017;41(5):474–5. https://doi.org/10.1016/j.jcjd.2017.07.005.
Desrochers HR, Schultz AT, Laffel LM. Use of diabetes technology in children: role of structured education for young people with diabetes and families. Endocrinol Metab Clin North Am. 2020;49(1):19–35. https://doi.org/10.1016/j.ecl.2019.11.001.
DeSalvo DJ, Miller KM, Hermann JM, Maahs DM, Hofer SE, Clements MA, Lilienthal E, Sherr JL, Tauschmann M, Holl RW, the TDE, Registries DPV. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: international comparison from the T1D Exchange and DPV Initiative. Pediatr Diabetes. 2018;19(7):1271–5. https://doi.org/10.1111/pedi.12711.
van den Boom L, Karges B, Auzanneau M, Rami-Merhar B, Lilienthal E, von Sengbusch S, Datz N, Schröder C, Kapellen T, Laimer M, Schmid SM, Müller H, Wolf J, Holl RW. Temporal trends and contemporary use of insulin pump therapy and glucose monitoring among children, adolescents, and adults with type 1 diabetes between 1995 and 2017. Diabetes Care. 2019;42(11):2050–6. https://doi.org/10.2337/dc19-0345.
Tauschmann M, Allen JM, Nagl K, Fritsch M, Yong J, Metcalfe E, Schaeffer D, Fichelle M, Schierloh U, Thiele AG, Abt D, Kojzar H, Mader JK, Slegtenhorst S, Barber N, Wilinska ME, Boughton C, Musolino G, Sibayan J, Cohen N, Kollman C, Hofer SE, Fröhlich-Reiterer E, Kapellen TM, Acerini CL, de Beaufort C, Campbell F, Rami-Merhar B, Hovorka R. Home use of day-and-night hybrid closed-loop insulin delivery in very young children: a multicenter, 3-week, randomized trial. Diabetes Care. 2019;42(4):594–600. https://doi.org/10.2337/dc18-1881.
Addala A, Auzanneau M, Miller K, Maier W, Foster N, Kapellen T, Walker A, Rosenbauer J, Maahs DM, Holl RW. A decade of disparities in diabetes technology use and hba(1c) in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care. 2021;44(1):133–40. https://doi.org/10.2337/dc20-0257.
Commissariat PV, Boyle CT, Miller KM, Mantravadi MG, DeSalvo DJ, Tamborlane WV, Van Name MA, Anderson BJ, DiMeglio LA, Laffel LM. Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers. Diabetes Technol Ther. 2017;19(6):363–9. https://doi.org/10.1089/dia.2016.0375.
Sinisterra M, Wang CH, Marks BE, Barber J, Tully C, Monaghan M, Hilliard ME, Streisand R. Patterns of continuous glucose monitor use in young children throughout the first 18 months following type 1 diabetes diagnosis. Diabetes Technol Ther. 2021;23(11):777–81. https://doi.org/10.1089/dia.2021.0183.
Lipman TH, Smith JA, Patil O, Willi SM, Hawkes CP. Racial disparities in treatment and outcomes of children with type 1 diabetes. Pediatr Diabetes. 2021;22(2):241–8. https://doi.org/10.1111/pedi.13139.
Sheikh K, Bartz SK, Lyons SK, DeSalvo DJ. Diabetes device use and glycemic control among youth with type 1 diabetes: a single-center, cross-sectional study. Journal Diabetes Res. 2018;2018:5162162. https://doi.org/10.1155/2018/5162162.
Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-world use of a new hybrid closed loop improves glycemic control in youth with type 1 diabetes. Diabetes Technol Ther. 2021;23(12):837–43. https://doi.org/10.1089/dia.2021.0165.
Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA. Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes. Diabetes Technol Ther. 2019;21(9):493–8. https://doi.org/10.1089/dia.2019.0142.
•• Musolino G, Dovc K, Boughton CK, Tauschmann M, Allen JM, Nagl K, Fritsch M, Yong J, Metcalfe E, Schaeffer D, Fichelle M, Schierloh U, Thiele AG, Abt D, Kojzar H, Mader JK, Slegtenhorst S, Ashcroft N, Wilinska ME, Sibayan J, Cohen N, Kollman C, Hofer SE, Fröhlich-Reiterer E, Kapellen TM, Acerini CL, de Beaufort C, Campbell F, Rami-Merhar B, Hovorka R. Reduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes. Pediatr Diabetes. 2019;20(6):794–9. https://doi.org/10.1111/pedi.12872. A hybrid closed loop-insulin delivery intervention demonstrated reduced diabetes burdens and improved quality of sleep in parents and children with type 1 diabetes.
Sinisterra M, Hamburger S, Tully C, Hamburger E, Jaser S, Streisand R. Young children with type 1 diabetes: sleep, health-related quality of life, and continuous glucose monitor use. Diabetes Technol Ther. 2020;22(8):639–42. https://doi.org/10.1089/dia.2019.0437.
Burckhardt MA, Fried L, Bebbington K, Hancock M, Nicholas JA, Roberts A, Abraham MB, Davis EA, Jones TW. Use of remote monitoring with continuous glucose monitoring in young children with type 1 diabetes: the parents’ perspective. Diabet Med. 2019;36(11):1453–9. https://doi.org/10.1111/dme.14061.
•• Patton SR, Clements MA, Marker AM, Nelson EL. Intervention to reduce hypoglycemia fear in parents of young kids using video-based telehealth (REDCHiP). Pediatr Diabetes. 2020;21(1):112–9. https://doi.org/10.1111/pedi.12934. A telehealth video intervention for parents of young children with T1D demonstrated a significant reduction in hypoglycemia fear and stress.
Gupta OT, MacKenzie M, Burris A, Jenkins BB, Collins N, Shade M, Santa-Sosa E, Stewart SM, White PC. Camp-based multi-component intervention for families of young children with type 1 diabetes: a pilot and feasibility study. Pediatr Diabetes. 2018;19(4):761–8. https://doi.org/10.1111/pedi.12624.
•• SENCE Study Group. A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with fingerstick blood glucose monitoring in very young children with type 1 diabetes. Diabetes Care. 2021;44(2):464–72. https://doi.org/10.2337/dc20-1060. A CGM and family behavioral intervention improved parental well-being and significantly reduced hypoglycemic events in young children with T1D.
Mackey ER, Herbert L, Monaghan M, Cogen F, Wang J, Streisand R. The feasibility of a pilot intervention for parents of young children newly diagnosed with type 1 diabetes. Clin Pract Pediatr Psychol. 2016;4(1):35–50. https://doi.org/10.1037/cpp0000123.
•• Tournilhac C, Dolladille C, Armouche S, Vial S, Brouard J. Evaluation of a new training program to reassure primary school teachers about glucagon injection in children with type 1 diabetes during the 2017–2018 school year. Arch Pediatr. 2020;27(4):212–8. https://doi.org/10.1016/j.arcped.2020.02.002. A video training program for primary school teachers significantly improved confidence in administering glucagon to students with T1D during severe hypoglycemia.
Lohan A, Mitchell AE, Filus A, Sofronoff K, Morawska A. Positive parenting for healthy living (Triple P) for parents of children with type 1 diabetes: protocol of a randomised controlled trial. BMC Pediatr. 2016;16(1):158. https://doi.org/10.1186/s12887-016-0697-4.
Marker AM, Monzon AD, Goggin KJ, Clements MA, Patton SR. Iterative development of a web-based intervention for families of young children with type 1 diabetes: DIPPer academy. Clin Pract Pediatr Psychol. 2019;7(1):20–30. https://doi.org/10.1037/cpp0000263.
Wysocki T, Pierce J, Caldwell C, Aroian K, Miller L, Farless R, Hafezzadeh I, McAninch T, Lee JM. A web-based coping intervention by and for parents of very young children with type 1 diabetes: user-centered design. JMIR diabetes. 2018;3(4):e16. https://doi.org/10.2196/diabetes.9926.
Berget C, Driscoll KA, Lagges A, Lange S, DiMeglio LA, Hannon TS, Woerner SE, Iturralde E, Barley RC, Hanes S, Hood KK, Buckingham BB. Optimizing the use of continuous glucose monitoring in young children with type 1 diabetes with an adaptive study design and multiple randomizations. Contemp Clin Trials. 2019;82:60–5. https://doi.org/10.1016/j.cct.2019.05.008.
d’Annunzio G, Maffeis C, Cherubini V, Rabbone I, Scaramuzza A, Schiaffini R, Minuto N, Piccolo G, Maghnie M. Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia. Diabetes Res Clin Pract. 2020;168:108372. https://doi.org/10.1016/j.diabres.2020.108372.
Predieri B, Leo F, Candia F, Lucaccioni L, Madeo SF, Pugliese M, Vivaccia V, Bruzzi P, Iughetti L. Glycemic control improvement in Italian children and adolescents with type 1 diabetes followed through telemedicine during lockdown due to the COVID-19 pandemic. Front Endocrinol (Lausanne). 2020;11:595735. https://doi.org/10.3389/fendo.2020.595735.
Schiaffini R, Barbetti F, Rapini N, Inzaghi E, Deodati A, Patera IP, Matteoli MC, Ciampalini P, Carducci C, Lorubbio A, Schiaffini G, Cianfarani S. School and pre-school children with type 1 diabetes during Covid-19 quarantine: the synergic effect of parental care and technology. Diabetes Res Clin Pract. 2020;166:108302. https://doi.org/10.1016/j.diabres.2020.108302.
Wang CH, Hilliard ME, Carreon SA, Jones J, Rooney K, Barber JR, Tully C, Monaghan M, Streisand R. Predictors of mood, diabetes-specific and COVID-19-specific experiences among parents of early school-age children with type 1 diabetes during initial months of the COVID-19 pandemic. Pediatr Diabetes. 2021;22(7):1071–80. https://doi.org/10.1111/pedi.13255.
Inverso H, Abadula F, Morrow T, LeStourgeon L, Parmar A, Streisand R, Jaser SS. Pivoting during a pandemic: lessons learned from transitioning a multisite randomized controlled trial to a remote protocol in response to COVID-19. Transl Behav Med. 2021. https://doi.org/10.1093/tbm/ibab103.
Patton SR, Monzon AD, Marker AM, Clements MA. A nonrandomized pilot of a group video-based telehealth intervention to reduce diabetes distress in parents of youth with type 1 diabetes mellitus. Can J Diabetes. 2021. https://doi.org/10.1016/j.jcjd.2021.10.007.
Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020;32(8):931–9. https://doi.org/10.1080/09540121.2019.1622637.
Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013;27(9):529–32. https://doi.org/10.1089/apc.2013.0185.
Standards of Medical Care in Diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14-S80. https://doi.org/10.2337/dc14-s014
11. Children and Adolescents. Diabetes Care. 2015;38(Suppl 1):S70-S6. https://doi.org/10.2337/dc15-S014
Funding
This work is supported by NIH, NIDDK 5R01DK102561-05, awarded to Randi Streisand, PhD.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors do not have existing conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Psychosocial Aspects
Rights and permissions
About this article
Cite this article
Monaghan, M., Bryant, B., Inverso, H. et al. Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research. Curr Diab Rep 22, 247–256 (2022). https://doi.org/10.1007/s11892-022-01465-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-022-01465-0